# Seth M. Steinberg

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/seth-m-steinberg/

## Facts

| Field | Value |
| --- | --- |
| Citations | 88,260 |
| Field | Lymphoma Diagnosis and Treatment |
| h-index | 150 |
| i10-index | 734 |
| Last Known Institution | National Institutes of Health |
| OpenAlex ID | https://openalex.org/A5044239219 |
| ORCID iD | 0000-0002-8280-551X |
| Works | 1,644 |

## Researcher papers

Showing 12 of 25.

- [Use of proteomic patterns in serum to identify ovarian cancer](https://scholariq.org/papers/use-of-proteomic-patterns-in-serum-to-identify-ovarian-cancer/)
- [T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial](https://scholariq.org/papers/t-cells-expressing-cd19-chimeric-antigen-receptors-for-acute-lymphoblastic/)
- [A Randomized Trial of Bevacizumab, an Anti–Vascular Endothelial Growth Factor Antibody, for Metastatic Renal Cancer](https://scholariq.org/papers/a-randomized-trial-of-bevacizumab-an-anti-vascular-endothelial-growth-factor/)
- [Durable Complete Responses in Heavily Pretreated Patients with Metastatic Melanoma Using T-Cell Transfer Immunotherapy](https://scholariq.org/papers/durable-complete-responses-in-heavily-pretreated-patients-with-metastatic/)
- [Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma](https://scholariq.org/papers/cancer-regression-and-autoimmunity-induced-by-cytotoxic-t-lymphocyte-associated/)
- [Randomized prospective study of the benefit of adjuvant radiation therapy in the treatment of soft tissue sarcomas of the extremity.](https://scholariq.org/papers/randomized-prospective-study-of-the-benefit-of-adjuvant-radiation-therapy-in-the/)
- [Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials](https://scholariq.org/papers/long-term-outcomes-for-neoadjuvant-versus-adjuvant-chemotherapy-in-early-breast/)
- [Age, Thymopoiesis, and CD4+ T-Lymphocyte Regeneration after Intensive Chemotherapy](https://scholariq.org/papers/age-thymopoiesis-and-cd4-t-lymphocyte-regeneration-after-intensive-chemotherapy/)
- [Ten-Year Results of a Comparison of Conservation with Mastectomy in the Treatment of Stage I and II Breast Cancer](https://scholariq.org/papers/ten-year-results-of-a-comparison-of-conservation-with-mastectomy-in-the/)
- [Identification of essential genes for cancer immunotherapy](https://scholariq.org/papers/identification-of-essential-genes-for-cancer-immunotherapy/)
- [Selumetinib in Children with Inoperable Plexiform Neurofibromas](https://scholariq.org/papers/selumetinib-in-children-with-inoperable-plexiform-neurofibromas/)
- [Eighteen‐year results in the treatment of early breast carcinoma with mastectomy versus breast conservation therapy](https://scholariq.org/papers/eighteen-year-results-in-the-treatment-of-early-breast-carcinoma-with-mastectomy/)

## Researcher topics

- [Lymphoma Diagnosis and Treatment](https://scholariq.org/topics/lymphoma-diagnosis-and-treatment/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Immunotherapy and Immune Responses](https://scholariq.org/topics/immunotherapy-and-immune-responses/)
- [Sarcoma Diagnosis and Treatment](https://scholariq.org/topics/sarcoma-diagnosis-and-treatment/)
- [Prostate Cancer Treatment and Research](https://scholariq.org/topics/prostate-cancer-treatment-and-research/)

## Researcher university

- [National Institutes of Health](https://scholariq.org/institutions/national-institutes-of-health/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.
